GetTopicDetailResponse(id=d774349226, topicName=BiTEs, introduction=BiTEs, content=null, image=null, comments=1, allHits=296, url=https://h5.medsci.cn/topic?id=3492, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=92677, tagList=[TagDto(tagId=92677, tagName=BiTEs)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1780348, encodeId=031a1e803483b, content=<a href='/topic/show?id=d774349226' target=_blank style='color:#2F92EE;'>#BiTEs#</a>, objectTitle=Nat Biotech | 針對(duì)腫瘤抗原異質(zhì)性問(wèn)題，提出CAR-T與BiTEs聯(lián)合的免疫療法，產(chǎn)生強(qiáng)有力的特異性抗腫瘤效應(yīng), objectType=article, longId=176417, objectId=1f141e6417a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f141e6417a6, replyNumber=0, likeNumber=58, createdTime=2020-02-09, rootId=0, userName=124987cdm26暫無(wú)昵稱, userId=e3fb2500073, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f141e6417a6, moduleTitle=Nat Biotech | 針對(duì)腫瘤抗原異質(zhì)性問(wèn)題，提出CAR-T與BiTEs聯(lián)合的免疫療法，產(chǎn)生強(qiáng)有力的特異性抗腫瘤效應(yīng), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=1f141e6417a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
